REPORT ID 17976

Global Autoimmune Disease Therapeutics Market Size, Status and Forecast 2022

Publish Date
03-Oct-17
Pages
100
Format
Electronic (PDF)

This report studies the global Autoimmune Disease Therapeutics market, analyzes and researches the Autoimmune Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Pfizer
    Novartis
    Johnson & Johnson Services
    Merck
    Sanofi
    Abott
    Bristol-Myers Squibb
    Amgen
    Bayer
    F. Hoffmann-La Roche
    Eli Lilly and Company

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Autoimmune Disease Therapeutics can be split into
    Immunosuppressants
    Anti-Inflammatory Drugs
    Corticosteroids
    Nonsteroidal Anti-inflammatory Drugs
    Biologics
    Other

Market segment by Application, Autoimmune Disease Therapeutics can be split into
    Hospitals
    Clinics
    Independent Pharmacies
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Autoimmune Disease Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Autoimmune Disease Therapeutics
    1.1  Autoimmune Disease Therapeutics Market Overview
        1.1.1 Autoimmune Disease Therapeutics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Autoimmune Disease Therapeutics Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Autoimmune Disease Therapeutics Market by Type
        1.3.1 Immunosuppressants
        1.3.2 Anti-Inflammatory Drugs
        1.3.3 Corticosteroids
        1.3.4 Nonsteroidal Anti-inflammatory Drugs
        1.3.5 Biologics
        1.3.6 Other
    1.4 Autoimmune Disease Therapeutics Market by End Users/Application
        1.4.1 Hospitals
        1.4.2 Clinics
        1.4.3 Independent Pharmacies
        1.4.4 Other

2 Global Autoimmune Disease Therapeutics Competition Analysis by Players
    2.1 Autoimmune Disease Therapeutics Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Pfizer
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Novartis
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Johnson & Johnson Services
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Merck
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Sanofi
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Abott
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Bristol-Myers Squibb
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Amgen
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Bayer
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 F. Hoffmann-La Roche
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Autoimmune Disease Therapeutics Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Eli Lilly and Company

4 Global Autoimmune Disease Therapeutics Market Size by Type and Application (2012-2017)
    4.1 Global Autoimmune Disease Therapeutics Market Size by Type (2012-2017)
    4.2 Global Autoimmune Disease Therapeutics Market Size by Application (2012-2017)
    4.3 Potential Application of Autoimmune Disease Therapeutics in Future
    4.4 Top Consumer/End Users of Autoimmune Disease Therapeutics

5 United States Autoimmune Disease Therapeutics Development Status and Outlook
    5.1 United States Autoimmune Disease Therapeutics Market Size (2012-2017)
    5.2 United States Autoimmune Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Autoimmune Disease Therapeutics Development Status and Outlook
    6.1 EU Autoimmune Disease Therapeutics Market Size (2012-2017)
    6.2 EU Autoimmune Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Autoimmune Disease Therapeutics Development Status and Outlook
    7.1 Japan Autoimmune Disease Therapeutics Market Size (2012-2017)
    7.2 Japan Autoimmune Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Autoimmune Disease Therapeutics Development Status and Outlook
    8.1 China Autoimmune Disease Therapeutics Market Size (2012-2017)
    8.2 China Autoimmune Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Autoimmune Disease Therapeutics Development Status and Outlook
    9.1 India Autoimmune Disease Therapeutics Market Size (2012-2017)
    9.2 India Autoimmune Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Autoimmune Disease Therapeutics Development Status and Outlook
    10.1 Southeast Asia Autoimmune Disease Therapeutics Market Size (2012-2017)
    10.2 Southeast Asia Autoimmune Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Autoimmune Disease Therapeutics Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Autoimmune Disease Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.2 EU Autoimmune Disease Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Autoimmune Disease Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.4 China Autoimmune Disease Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.5 India Autoimmune Disease Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Autoimmune Disease Therapeutics Revenue and Growth Rate (2017-2022)
    11.2 Global Autoimmune Disease Therapeutics Market Size (Value) by Type (2017-2022)
    11.3 Global Autoimmune Disease Therapeutics Market Size by Application (2017-2022)

12 Autoimmune Disease Therapeutics Market Dynamics
    12.1 Autoimmune Disease Therapeutics Market Opportunities
    12.2 Autoimmune Disease Therapeutics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Autoimmune Disease Therapeutics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Autoimmune Disease Therapeutics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source